These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24594451)

  • 21. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.
    Williamson DA; Barrett LK; Rogers BA; Freeman JT; Hadway P; Paterson DL
    Clin Infect Dis; 2013 Jul; 57(2):267-74. PubMed ID: 23532481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
    Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K
    Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection after transrectal ultrasound-guided prostate biopsy.
    Lee SJ
    Korean J Urol; 2015 May; 56(5):346-50. PubMed ID: 25964834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection.
    Tasbakan MI; Pullukcu H; Sipahi OR; Yamazhan T; Ulusoy S
    Int J Antimicrob Agents; 2012 Dec; 40(6):554-6. PubMed ID: 23063743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
    Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
    Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    Seitz M; Stief C; Waidelich R; Bader M; Tilki D
    World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of the antimicrobial drug used to prevent febrile infection following prostate needle biopsy].
    Kobayashi S; Maki T; Kobayashi T; Hamaguchi M; Yoshikawa M; Sakamoto N; Iguchi A
    Hinyokika Kiyo; 2014 May; 60(5):227-30. PubMed ID: 24894858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
    Pinheiro HS; Mituiassu AM; Carminatti M; Braga AM; Bastos MG
    Transplant Proc; 2010 Mar; 42(2):486-7. PubMed ID: 20304172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
    Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
    Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.